JP Morgan Chase’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$355M Sell
1,268,384
-264,339
-17% -$69.5M 0.02% 559
2026
Q1
$404M Buy
1,532,723
+245,546
+19% +$66.5M 0.03% 466
2025
Q4
$323M Buy
1,287,177
+213,136
+20% +$56.6M 0.02% 508
2025
Q3
$308M Sell
1,074,041
-229,266
-18% -$61.4M 0.02% 557
2025
Q2
$342M Buy
1,303,307
+43,661
+3% +$10.6M 0.02% 517
2025
Q1
$293M Sell
1,259,646
-84,732
-6% -$20.6M 0.02% 553
2024
Q4
$308M Sell
1,344,378
-586,017
-30% -$134M 0.02% 517
2024
Q3
$431M Buy
1,930,395
+167,137
+9% +$36.7M 0.03% 428
2024
Q2
$359M Buy
1,763,258
+30,940
+2% +$6.29M 0.03% 441
2024
Q1
$378M Buy
1,732,318
+221,017
+15% +$48.7M 0.03% 465
2023
Q4
$344M Buy
1,511,301
+75,592
+5% +$15.9M 0.03% 456
2023
Q3
$289M Sell
1,435,709
-236,562
-14% -$49.9M 0.03% 445
2023
Q2
$347M Sell
1,672,271
-71,091
-4% -$13.8M 0.04% 407
2023
Q1
$344M Sell
1,743,362
-719,464
-29% -$148M 0.04% 385
2022
Q4
$498M Sell
2,462,826
-33,507
-1% -$6.55M 0.07% 287
2022
Q3
$439M Buy
2,496,333
+279,845
+13% +$57.3M 0.06% 295
2022
Q2
$446M Buy
2,216,488
+737,330
+50% +$157M 0.06% 301
2022
Q1
$335M Sell
1,479,158
-10,871
-0.7% -$2.56M 0.04% 409
2021
Q4
$402M Buy
1,490,029
+35,800
+2% +$8.86M 0.05% 392
2021
Q3
$352M Sell
1,454,229
-166,506
-10% -$42M 0.04% 407
2021
Q2
$384M Buy
1,620,735
+20,254
+1% +$4.61M 0.05% 415
2021
Q1
$351M Sell
1,600,481
-57,034
-3% -$11.4M 0.05% 398
2020
Q4
$290M Buy
1,657,515
+2,110
+0.1% +$364K 0.04% 423
2020
Q3
$265M Sell
1,655,405
-118,980
-7% -$18.9M 0.04% 393
2020
Q2
$253M Buy
1,774,385
+51,162
+3% +$7.08M 0.05% 370
2020
Q1
$187M Sell
1,723,223
-30,848
-2% -$4.44M 0.04% 384
2019
Q4
$255M Sell
1,754,071
-228,188
-12% -$32.9M 0.05% 373
2019
Q3
$286M Buy
1,982,259
+102,018
+5% +$14.9M 0.06% 338
2019
Q2
$276M Buy
1,880,241
+45,037
+2% +$6.28M 0.05% 347
2019
Q1
$241M Sell
1,835,204
-92,560
-5% -$11.4M 0.05% 381
2018
Q4
$209M Buy
1,927,764
+12,055
+0.6% +$1.61M 0.05% 390
2018
Q3
$286M Buy
1,915,709
+248,920
+15% +$37.9M 0.05% 352
2018
Q2
$257M Buy
1,666,789
+30,867
+2% +$4.66M 0.05% 375
2018
Q1
$227M Sell
1,635,922
-29,594
-2% -$4.35M 0.05% 391
2017
Q4
$228M Buy
1,665,516
+93,065
+6% +$12.3M 0.05% 394
2017
Q3
$202M Buy
1,572,451
+573,696
+57% +$76.5M 0.04% 413
2017
Q2
$132M Buy
998,755
+210,647
+27% +$25.8M 0.03% 521
2017
Q1
$97.1M Buy
788,108
+458,903
+139% +$54.3M 0.02% 640
2016
Q4
$36.3M Sell
329,205
-146,337
-31% -$16.3M 0.01% 1094
2016
Q3
$56.2M Buy
475,542
+15,441
+3% +$1.82M 0.01% 778
2016
Q2
$51.5M Buy
460,101
+31,786
+7% +$3.42M 0.01% 823
2016
Q1
$43.1M Sell
428,315
-73,547
-15% -$7.05M 0.01% 889
2015
Q4
$53.3M Buy
501,862
+402,293
+404% +$41.5M 0.01% 782
2015
Q3
$9.28M Sell
99,569
-108,283
-52% -$11.2M ﹤0.01% 1824
2015
Q2
$21.6M Sell
207,852
-357,095
-63% -$37.2M 0.01% 1353
2015
Q1
$61.2M Sell
564,947
-121,343
-18% -$12.5M 0.01% 809
2014
Q4
$63.6M Buy
686,290
+190,236
+38% +$16.8M 0.01% 823
2014
Q3
$43.4M Buy
496,054
+137,024
+38% +$12.4M 0.01% 972
2014
Q2
$31.6M Buy
359,030
+185,248
+107% +$16M 0.01% 1084
2014
Q1
$14.7M Sell
173,782
-52,434
-23% -$4.18M ﹤0.01% 1510
2013
Q4
$17.8M Sell
226,216
-657,636
-74% -$56.1M 0.01% 1400
2013
Q3
$75.3M Buy
883,852
+322,080
+57% +$27.1M 0.02% 629
2013
Q2
$48.3M Buy
+561,772
New +$46.6M 0.02% 765

Other funds holding LH

JP Morgan Chase's LH Position: Q2 2026 in Review

JP Morgan Chase reduced its Labcorp (LH) stake by 17% in Q2 2026, selling an estimated $69.5M and leaving 1,268,384 shares worth $355M. The position accounts for 0.02% of the portfolio, ranked #559.

JP Morgan Chase first reported a position in LH in Q2 2013 and has held it in 53 quarters since. The position peaked at $498M in Q4 2022. 1,054 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • JP Morgan Chase held 1,268,384 shares of Labcorp worth $355M as of Q2 2026.
  • JP Morgan Chase sold 264,339 Labcorp shares in Q2 2026, an estimated $69.5M.
  • Labcorp made up 0.02% of JP Morgan Chase's portfolio in Q2 2026, its #559 holding.
  • JP Morgan Chase first reported a position in Labcorp in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's Labcorp position peaked at $498M in Q4 2022.
  • 1,054 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.